As we enter a new year, it’s time to look ahead to the changes that will help our industry conduct ethical, scientifically-rigorous research and continue to advance new therapies.

In this interactive webinar, Dr. Lindsay McNair leads a panel of clinical trial experts in sharing their thoughts about the most important trends, disruptions, and innovations they anticipate in 2022 for sponsors, CROs, sites and patients.


Meet the Speakers

Moderator

Lindsay McNair photo

Lindsay McNair, MD, MPH, MSB

Chief Medical Officer, WCG

FULL BIO

Panelist

Photo of Arturo Morales

Arturo Morales, PhD

Chief Technology Officer, WCG Analgesic Solutions

FULL BIO

Panelist

Photo of Daniel Kavanagh

Daniel Kavanagh, PhD

Senior Scientific Advisor, Gene Therapy, WCG IRB

FULL BIO

Panelist

Photo of Dave Borasky

David A. Borasky, MPH, CIP

Vice President, IRB Compliance, WCG IRB

FULL BIO

Panelist

Bio photo of Luca Pani, MD

Luca Pani, MD

VP, Regulatory Strategy and Market Access Innovation, WCG VeraSci
Panelist

Photo of Megan Trost

Megan Trost

Vice President, Study Start Up & Administration

FULL BIO

Panelist

Bio photo of Richard Keefe, PhD

Richard Keefe, PhD

Co-Founder & CEO, WCG VeraSci

FULL BIO

Panelist

Photo of Sandra Smith.

Sandra Smith, RN, MSN, AOCN

Senior Vice President, Clinical Solutions & Strategic Partnerships

FULL BIO

Panelist

Bio photo of Suzanne Caruso

Suzanne Caruso

Senior Vice President, Insights and Analytics

FULL BIO